Cathie's Ark Logo

All 142 XBI Holdings

XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. XBI is suitable for investors seeking to capitalize on the growth potential and innovation within the biotechnology industry. Due to the sector's inherent volatility, XBI might experience significant price swings and is considered a higher-risk investment compared to broader market funds.

**Charts show 1 year
Rank
Ticker
Company
Weight
CountryMarket CapIndustry
1IMGN
ImmunoGen Inc Logo
ImmunoGen Inc
5.97%United States$1.23bBiotechnology
2IMVT
Immunovant Inc Logo
Immunovant Inc
1.91%United States$1.87bBiotechnology
3ISEE
IVERIC bio Inc Logo
IVERIC bio Inc
1.87%United States$3.00bBiotechnology
4RXDX
Prometheus Biosciences Inc Logo
Prometheus Biosciences Inc
1.77%United States$1.79bBiotechnology
5BPMC
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
1.68%United States$3.01bBiotechnology
6CRSP
Crispr Therapeutics AG Logo
Crispr Therapeutics AG
1.56%United States$4.10bBiotechnology
7TWST
Twist Bioscience Corp Logo
Twist Bioscience Corp
1.54%United States$1.57bDiagnostics & Research
7CTIC
CTi Biopharma Corp Logo
CTi Biopharma Corp
1.54%United States$739.60mBiotechnology
9IONS
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
1.47%United States$5.57bBiotechnology
10MRTX
Mirati Ther Logo
Mirati Ther
1.46%United States$5.38bBiotechnology
11INSM
Insmed Inc Logo
Insmed Inc
1.41%United States$2.71bBiotechnology
12PCVX
Vaxcyte Inc Logo
Vaxcyte Inc
1.39%United States$3.55bBiotechnology
13EXEL
Exelixis Inc Logo
Exelixis Inc
1.32%United States$5.58bBiotechnology
14RYTM
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
1.27%United States$1.54bBiotechnology
15VRTX
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
1.25%United States$82bBiotechnology
15SGEN
Seagen Inc Logo
Seagen Inc
1.25%United States$23bBiotechnology
17NBIX
Neurocrine Biosciences Inc Logo
Neurocrine Biosciences Inc